Immunology
-
Memory B cells control SARS-CoV-2 variants upon mRNA vaccination of naive and COVID-19 recovered individuals
This article has 30 authors:Reviewed by ScreenIT
-
A SARS-CoV-2 spike ferritin nanoparticle vaccine protects against heterologous challenge with B.1.1.7 and B.1.351 virus variants in Syrian golden hamsters
This article has 56 authors:Reviewed by ScreenIT
-
Increased sensitivity of SARS-CoV-2 to type III interferon in human intestinal epithelial cells
This article has 6 authors:Reviewed by ScreenIT
-
Interferon-stimulated and metallothionein-expressing macrophages are associated with acute and chronic allograft dysfunction after lung transplantation
This article has 12 authors:Reviewed by ScreenIT
-
Proinflammatory Responses in SARS-CoV-2 and Soluble Spike Glycoprotein S1 Subunit Activated Human Macrophages
This article has 5 authors:Reviewed by ScreenIT
-
COVID- e Vax, an electroporated plasmid DNA vaccine candidate encoding the SARS-CoV-2 Receptor Binding Domain, elicits protective immune responses in animal models of COVID-19
This article has 55 authors:Reviewed by ScreenIT
-
Control of SARS-CoV-2 infection after Spike DNA or Spike DNA+Protein co-immunization in rhesus macaques
This article has 19 authors:Reviewed by ScreenIT
-
NAMPT-derived NAD+ fuels PARP1 to promote skin inflammation through parthanatos cell death
This article has 18 authors:Reviewed by Review Commons
-
Immunogenicity and In vivo protection of a variant nanoparticle vaccine that confers broad protection against emerging SARS-CoV-2 variants
This article has 21 authors:Reviewed by ScreenIT
-
The ChAdOx1 vectored vaccine, AZD2816, induces strong immunogenicity against SARS-CoV-2 beta (B.1.351) and other variants of concern in preclinical studies
This article has 26 authors:Reviewed by ScreenIT